- Home
- RCMT vs LUCD Comparison
RCMT vs LUCD Comparison
Compare RCMT & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- LUCD
- Stock Information
- Founded
- RCMT 1971
- LUCD 2018
- Country
- RCMT United States
- LUCD United States
- Employees
- RCMT N/A
- LUCD N/A
- Industry
- RCMT Professional Services
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RCMT Consumer Discretionary
- LUCD Health Care
- Exchange
- RCMT Nasdaq
- LUCD Nasdaq
- Market Cap
- RCMT 133.5M
- LUCD 135.6M
- IPO Year
- RCMT N/A
- LUCD 2021
- Fundamental
- Price
- RCMT $22.89
- LUCD $1.40
- Analyst Decision
- RCMT Strong Buy
- LUCD Strong Buy
- Analyst Count
- RCMT 2
- LUCD 4
- Target Price
- RCMT $33.50
- LUCD $3.88
- AVG Volume (30 Days)
- RCMT 36.6K
- LUCD 1.1M
- Earning Date
- RCMT 05-07-2025
- LUCD 05-14-2025
- Dividend Yield
- RCMT N/A
- LUCD N/A
- EPS Growth
- RCMT N/A
- LUCD N/A
- EPS
- RCMT 1.74
- LUCD N/A
- Revenue
- RCMT $290,914,000.00
- LUCD $4,173,000.00
- Revenue This Year
- RCMT $16.29
- LUCD $98.50
- Revenue Next Year
- RCMT $6.16
- LUCD $208.02
- P/E Ratio
- RCMT $13.19
- LUCD N/A
- Revenue Growth
- RCMT 8.53
- LUCD 39.89
- 52 Week Low
- RCMT $13.18
- LUCD $0.68
- 52 Week High
- RCMT $26.37
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- RCMT 69.07
- LUCD 58.18
- Support Level
- RCMT $22.10
- LUCD $1.21
- Resistance Level
- RCMT $23.49
- LUCD $1.70
- Average True Range (ATR)
- RCMT 0.91
- LUCD 0.11
- MACD
- RCMT -0.07
- LUCD 0.03
- Stochastic Oscillator
- RCMT 70.67
- LUCD 60.48
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.